Piroxicam cinnamate

This classification denotes a cyclooxygenase inhibitor with the molecular formula C24H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E8Q32N75N, chemically known as 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide, cinnamate (ester) but more generally known as piroxicam cinnamate, which bears US NIH Compound Identifier 6436090. European Medicines Agency schedules Piroxicam cinnamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14900MIG. Most nations, for tariff and trade purposes, schedule piroxicam cinnamate under HS 29349990 and SITC 51579. As of Q4 2014, PIROXICAM CINNAMATE remains US FDA's Preferred Term for this commodity. Piroxicam cinnamate bears US NLM identifiers UMLS ID C0071149 and NCI Concept Code C73032. SMILES: CN1C(=C(C2CCCCC2S1(=O)=O)OC(=O)/C=C/C3CCCCC3)C(=O)NC4CCCCN4.